SI2638894T1 - Farmacevtski sestavek, ki vsebuje fosfolipid - Google Patents

Farmacevtski sestavek, ki vsebuje fosfolipid

Info

Publication number
SI2638894T1
SI2638894T1 SI201330401A SI201330401A SI2638894T1 SI 2638894 T1 SI2638894 T1 SI 2638894T1 SI 201330401 A SI201330401 A SI 201330401A SI 201330401 A SI201330401 A SI 201330401A SI 2638894 T1 SI2638894 T1 SI 2638894T1
Authority
SI
Slovenia
Prior art keywords
pharmaceutical composition
composition containing
containing phospholipid
phospholipid
pharmaceutical
Prior art date
Application number
SI201330401A
Other languages
English (en)
Inventor
Bernd G. Seigfried
Original Assignee
Mika Pharma Gesellschaft Fuer Die Entwicklung Und Vermarktung Pharmazeutischer Produkte Mbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mika Pharma Gesellschaft Fuer Die Entwicklung Und Vermarktung Pharmazeutischer Produkte Mbh filed Critical Mika Pharma Gesellschaft Fuer Die Entwicklung Und Vermarktung Pharmazeutischer Produkte Mbh
Publication of SI2638894T1 publication Critical patent/SI2638894T1/sl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/899Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SI201330401A 2012-05-15 2013-03-18 Farmacevtski sestavek, ki vsebuje fosfolipid SI2638894T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102012009575 2012-05-15
DE102013004199A DE102013004199A1 (de) 2012-05-15 2013-03-12 Pharmazeutische Zusammensetzung
EP13001361.8A EP2638894B1 (de) 2012-05-15 2013-03-18 Pharmazeutische Zusammensetzung mit Phospholipid

Publications (1)

Publication Number Publication Date
SI2638894T1 true SI2638894T1 (sl) 2017-01-31

Family

ID=47901750

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201330401A SI2638894T1 (sl) 2012-05-15 2013-03-18 Farmacevtski sestavek, ki vsebuje fosfolipid

Country Status (18)

Country Link
EP (1) EP2638894B1 (sl)
JP (1) JP2013237669A (sl)
BR (1) BR102013011801B1 (sl)
CA (1) CA2815477C (sl)
CY (1) CY1118727T1 (sl)
DE (1) DE102013004199A1 (sl)
DK (1) DK2638894T3 (sl)
ES (1) ES2606031T3 (sl)
HR (1) HRP20161318T1 (sl)
HU (1) HUE029793T2 (sl)
LT (1) LT2638894T (sl)
MX (1) MX342069B (sl)
PL (1) PL2638894T3 (sl)
PT (1) PT2638894T (sl)
RS (1) RS55291B1 (sl)
RU (1) RU2659943C2 (sl)
SI (1) SI2638894T1 (sl)
SM (1) SMT201600419B (sl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10596117B1 (en) 2014-12-31 2020-03-24 Eric Morrison Lipoleosomes as carriers for aromatic amide anesthetic compounds
US10561627B2 (en) 2014-12-31 2020-02-18 Eric Morrison Ibuprofen nanoparticle carriers encapsulated with hermetic surfactant films
US11007161B1 (en) 2014-12-31 2021-05-18 Eric Morrison Ibuprofen nanoparticle carriers encapsulated with hermatic surfactant films

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2122975T3 (es) * 1991-07-05 1999-01-01 Rhone Poulenc Rorer Gmbh Composicion fosfolipidica.
US6113921A (en) * 1993-03-23 2000-09-05 Pharmos Corp. Topical and transdermal delivery system utilizing submicron oil spheres
DE4313402A1 (de) * 1993-04-23 1994-10-27 Hexal Pharma Gmbh Transdermale Wirkstoffzubereitung
DE69434199T2 (de) * 1993-10-07 2005-12-29 Odontex, Inc., Lawrence Absorptionsförderer für topische pharmazeutische formulierungen
CA2201358C (en) 1994-09-30 2004-06-08 Jurgen Regenold Pharmaceutical composition
KR20070063017A (ko) * 2004-09-24 2007-06-18 리포 케미컬즈 인크. 국소 적용 화합물용 전달 시스템
BRPI1006790B8 (pt) * 2009-07-24 2021-05-25 Mika Pharma Ges Fuer Die Entwicklung Und Vermarktung Pharmazeutischer Produkte Mbh método para desenvolver uma composição farmacêutica líquida a ser aplicada na pele como uma espuma e composição adequada para uso tópico

Also Published As

Publication number Publication date
HUE029793T2 (en) 2017-04-28
JP2013237669A (ja) 2013-11-28
DK2638894T3 (en) 2016-10-17
MX342069B (es) 2016-09-13
EP2638894B1 (de) 2016-09-14
BR102013011801B1 (pt) 2022-08-09
DE102013004199A1 (de) 2013-11-21
RU2013121269A (ru) 2014-11-20
CA2815477C (en) 2017-05-02
CA2815477A1 (en) 2013-11-15
BR102013011801A2 (pt) 2015-11-10
LT2638894T (lt) 2017-02-10
RS55291B1 (sr) 2017-03-31
HRP20161318T1 (hr) 2016-12-16
ES2606031T3 (es) 2017-03-17
PT2638894T (pt) 2016-12-13
EP2638894A1 (de) 2013-09-18
RU2659943C2 (ru) 2018-07-04
PL2638894T3 (pl) 2017-02-28
SMT201600419B (it) 2017-01-10
CY1118727T1 (el) 2017-07-12
MX2013005306A (es) 2013-11-26

Similar Documents

Publication Publication Date Title
HK1211209A1 (en) Pharmaceutical formulation containing thienotriazolodiazepine compounds
PL3181122T3 (pl) Kompozycja farmaceutyczna dazatynibu
ZA201501930B (en) Pharmaceutical composition
HK1209638A1 (en) Pharmaceutical compositions
EP2832730A4 (en) MIRABEGRAPHIC PHARMACEUTICAL COMPOSITION
HK1199821A1 (en) Oral pharmaceutical composition
SG11201405578TA (en) Pharmaceutical composition containing peptide
IL266415A (en) Innovative pharmaceutical composition
EP2815753A4 (en) ORAL PHARMACEUTICAL COMPOSITION
ZA201502987B (en) Pharmaceutical composition
LT2638894T (lt) Farmacinė kompozicija, turinti fosfolipido
EP2897590A4 (en) PHARMACEUTICAL COMPOSITION
EP2883546A4 (en) NOVEL DIFFERENTIALLY RELEASING PHARMACEUTICAL COMPOSITION CONTAINING THREE ACTIVE INGREDIENTS
GB201211153D0 (en) Pharmaceutical compositions
HK1204945A1 (en) Pharmaceutical formulation containing flupirtin
EP2851078A4 (en) PHARMACEUTICAL COMPOSITION
IL237221A (en) Preparations containing analogues of phospholipid drugs
IL238075A0 (en) pharmaceutical preparations
ZA201400751B (en) Pharmaceutical composition
GB201221130D0 (en) New pharmaceutical composition
GB201207628D0 (en) New pharmaceutical composition
GB201207701D0 (en) New pharmaceutical composition
GB201219234D0 (en) Pharmaceutical compositions
GB201213303D0 (en) Pharmaceutical compositions
GB201204810D0 (en) Pharmaceutical compositions